☆ 4.7 Letter

Strongyloides Hyperinfection Syndrome among COVID-19 Patients Treated with Corticosteroids

EMERGING INFECTIOUS DISEASES (2022)

Strongyloides in bronchoalveolar lavage fluid: practical implications in the COVID-19 era

Francesca F. Norman et al.

JOURNAL OF TRAVEL MEDICINE (2022)

添加到收藏夹

Letter Medicine, General & Internal

The other side of Filomena: risk of myocardial infarction associated with snowshoveling

Carla Jimenez Martinez et al.

MEDICINA CLINICA (2022)

添加到收藏夹

Article Infectious Diseases

Strongyloidesinfection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia

Valentina Marchese et al.

Summary: This report presents the first case of Strongyloides stercoralis infection in a COVID-19 patient following treatment with high-dose steroids and Tocilizumab, highlighting the risk of parasitic infections when treating severe COVID-19.

INFECTION (2021)

添加到收藏夹

Article Infectious Diseases

Corticosteroids in Covid-19 pandemic have the potential to unearth hidden burden of strongyloidiasis

Disha Gautam et al.

Summary: The COVID-19 pandemic has led to a significant proportion of patients developing strongyloidiasis hyperinfection, particularly in those with latent strongyloides infection. This highlights the importance of considering underlying infections when treating COVID-19.

IDCASES (2021)

添加到收藏夹

Article Immunology

COVID-19-Associated Eosinopenia in a Patient With Chronic Eosinophilia Due to Chronic Strongyloidiasis

Dimitri Stylemans et al.

Summary: Eosinopenia is frequently seen in patients with COVID-19, even in those with chronic eosinophilia. Screening for strongyloidiasis is recommended for all patients eligible for immunosuppressive therapy to prevent Strongyloides hyperinfection syndrome.

INFECTIOUS DISEASES IN CLINICAL PRACTICE (2021)

添加到收藏夹

Editorial Material Medicine, General & Internal